| Symbol | BRKR |
|---|---|
| Name | BRUKER CORP |
| Sector | INDUSTRIALS |
| Region | UNDEFINED |
| Industry | Laboratory Analytical Instruments |
| Address | 40 MANNING RD, BILLERICA, MA 01821 |
| Telephone | 978663-3660 |
| Fax | — |
| — | |
| Website | https://www.bruker.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | — |
| Description | Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, pharmaceutical, and biotechnology industries. It operates in four operating segments: Bruker BioSpin Group, Bruker Calid Group, Bruker Scientific Instruments Nano, and Bruker Energy & Supercon Technologies. The Bruker BioSpin Group and Bruker Calid Group are aggregated into BSI Life Science segment for reporting purposes, and it provides the highest revenue stream to the firm. The largest proportion of Brukers revenue comes from Europe, though the firm also has a significant presence in the United States and Asia. It has its major technical and manufacturing centers in Europe, North America, Southeast Asia, as well as sales offices throughout the world. Additional info from NASDAQ: |
Bruker - Bruker Announces Date and Time of First Quarter 2026 Earnings Release and Webcast
Read moreBruker Announces Date and Time of First Quarter 2026 Earnings Release and Webcast
Read moreBruker - Bruker Spatial Biology Showcases High Fidelity Spatial Data and Integrated Multi-platform Workflows for Unprecedented Multiomic Insights at AACR 2026
Read moreBruker Spatial Biology Showcases High Fidelity Spatial Data and Integrated Multi-platform Workflows for Unprecedented Multiomic Insights at AACR 2026
Read moreBruker - Bruker Launches MyGenius PRO®High-Throughput Sample-to-Answer Molecular Diagnostics System at ESCMID 2026
Read moreBruker - Bruker Expands Industry-Leading MALDIBiotyper® and IR Biotyper® Workflows for Microbial Identification and Outbreak Management
Read moreBruker Expands Industry-Leading MALDI Biotyper® and IR Biotyper® Workflows for Microbial Identification and Outbreak Management
Read moreBruker Launches MyGenius PRO® High-Throughput Sample-to-Answer Molecular Diagnostics System at ESCMID 2026
Read moreMunch Mark 🟡 adjusted position in 2.0K shares (1 derivative) of BRUKER CORP (BRKR) at $39.90 Transaction Date: Apr 15, 2026 | Filing ID: 000012
Read more